Drug company and former director are convicted of submitting falsified data to MHRA

The drug company Kappin and its former director Kamlesh Vaghjiani have been successfully prosecuted for knowingly providing false data to the UK’s drug regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), to obtain and then retain marketing authorisation for a hypothyroidism treatment.

In a UK first Vaghjiani and Kappin have been fined £50 000, having previously paid out nearly £1.1m that they made …

Source link

  • Share this post

Leave a Comment